Loading…
Frailty and cardiovascular mortality in more than 3 million US Veterans
Frailty is associated with an increased risk of all-cause mortality and cardiovascular (CV) events. Limited data exist from the modern era of CV prevention on the relationship between frailty and CV mortality. We hypothesized that frailty is associated with an increased risk of CV mortality. All US...
Saved in:
Published in: | European heart journal 2022-02, Vol.43 (8), p.818-826 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c399t-858c8c15c705f87af2c060ac8ae90c90dbabf18c471d2142f14cd593b96cec533 |
---|---|
cites | cdi_FETCH-LOGICAL-c399t-858c8c15c705f87af2c060ac8ae90c90dbabf18c471d2142f14cd593b96cec533 |
container_end_page | 826 |
container_issue | 8 |
container_start_page | 818 |
container_title | European heart journal |
container_volume | 43 |
creator | Shrauner, William Lord, Emily M Nguyen, Xuan-Mai T Song, Rebecca J Galloway, Ashley Gagnon, David R Driver, Jane A Gaziano, J Michael Wilson, Peter W F Djousse, Luc Cho, Kelly Orkaby, Ariela R |
description | Frailty is associated with an increased risk of all-cause mortality and cardiovascular (CV) events. Limited data exist from the modern era of CV prevention on the relationship between frailty and CV mortality. We hypothesized that frailty is associated with an increased risk of CV mortality.
All US Veterans aged ≥65 years who were regular users of Veteran Affairs care from 2002 to 2017 were included. Frailty was defined using a 31-item previously validated frailty index, ranging from 0 to 1. The primary outcome was CV mortality with secondary analyses examining the relationship between frailty and CV events (myocardial infarction, stroke, revascularization). Survival analysis models were adjusted for age, sex, ethnicity, geographic region, smoking, hyperlipidaemia, statin use, and blood pressure medication use. There were 3 068 439 US Veterans included in the analysis. Mean age was 74.1 ± 5.8 years in 2002, 76.0 ± 8.3 years in 2014, 98% male, and 87.5% White. In 2002, the median (interquartile range) frailty score was 0.16 (0.10-0.23). This increased and stabilized to 0.19 (0.10-0.32) for 2006-14. The presence of frailty was associated with an increased risk of CV mortality at every stage of frailty. Frailty was associated with an increased risk of myocardial infarction and stroke, but not revascularization.
In this population, both the presence and severity of frailty are tightly correlated with CV death, independent of underlying CV disease. This study is the largest and most contemporary evaluation of the relationship between frailty and CV mortality to date. Further work is needed to understand how this risk can be diminished.
Can an electronic frailty index identify adults aged 65 and older who are at risk of CV mortality and major CV events?
Among 3 068 439 US Veterans aged 65 and older, frailty was associated with an increased risk of CV mortality at every level of frailty. Frailty was also associated with an increased risk of myocardial infarction and stroke, but not revascularization.
Both the presence and severity of frailty are associated with CV mortality and major CV events, independent of underlying CV disease. |
doi_str_mv | 10.1093/eurheartj/ehab850 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9890630</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2610412466</sourcerecordid><originalsourceid>FETCH-LOGICAL-c399t-858c8c15c705f87af2c060ac8ae90c90dbabf18c471d2142f14cd593b96cec533</originalsourceid><addsrcrecordid>eNpVUU1LAzEQDaJorf4AL7JHL6uTZJMmF0GKVaHgwQ-8hdls1qZkdzXZFfrvbbEWPQ3D-5jHPELOKFxS0PzKDXHhMPbLK7fAUgnYIyMqGMu1LMQ-GQHVIpdSvR2R45SWAKAklYfkiBcaJgVjI3I3i-hDv8qwrTKLsfLdFyY7BIxZ08Ueg1-Dvt0sLusX2GY8a3wIvmuzl6fs1fUuYptOyEGNIbnT7RyTl9nt8_Q-nz_ePUxv5rnlWve5EsoqS4WdgKjVBGtmQQJahU6D1VCVWNZU2WJCK0YLVtPCVkLzUkvrrOB8TK5_fD-GsnGVdW0fMZiP6BuMK9OhN_-R1i_Me_dltNIgOawNLrYGsfscXOpN45N1IWDruiEZJikUlBVSrqn0h2pjl1J09e4MBbMpwOwKMNsC1przv_l2it-P82-K1Yce</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2610412466</pqid></control><display><type>article</type><title>Frailty and cardiovascular mortality in more than 3 million US Veterans</title><source>Oxford Journals Online</source><creator>Shrauner, William ; Lord, Emily M ; Nguyen, Xuan-Mai T ; Song, Rebecca J ; Galloway, Ashley ; Gagnon, David R ; Driver, Jane A ; Gaziano, J Michael ; Wilson, Peter W F ; Djousse, Luc ; Cho, Kelly ; Orkaby, Ariela R</creator><creatorcontrib>Shrauner, William ; Lord, Emily M ; Nguyen, Xuan-Mai T ; Song, Rebecca J ; Galloway, Ashley ; Gagnon, David R ; Driver, Jane A ; Gaziano, J Michael ; Wilson, Peter W F ; Djousse, Luc ; Cho, Kelly ; Orkaby, Ariela R</creatorcontrib><description>Frailty is associated with an increased risk of all-cause mortality and cardiovascular (CV) events. Limited data exist from the modern era of CV prevention on the relationship between frailty and CV mortality. We hypothesized that frailty is associated with an increased risk of CV mortality.
All US Veterans aged ≥65 years who were regular users of Veteran Affairs care from 2002 to 2017 were included. Frailty was defined using a 31-item previously validated frailty index, ranging from 0 to 1. The primary outcome was CV mortality with secondary analyses examining the relationship between frailty and CV events (myocardial infarction, stroke, revascularization). Survival analysis models were adjusted for age, sex, ethnicity, geographic region, smoking, hyperlipidaemia, statin use, and blood pressure medication use. There were 3 068 439 US Veterans included in the analysis. Mean age was 74.1 ± 5.8 years in 2002, 76.0 ± 8.3 years in 2014, 98% male, and 87.5% White. In 2002, the median (interquartile range) frailty score was 0.16 (0.10-0.23). This increased and stabilized to 0.19 (0.10-0.32) for 2006-14. The presence of frailty was associated with an increased risk of CV mortality at every stage of frailty. Frailty was associated with an increased risk of myocardial infarction and stroke, but not revascularization.
In this population, both the presence and severity of frailty are tightly correlated with CV death, independent of underlying CV disease. This study is the largest and most contemporary evaluation of the relationship between frailty and CV mortality to date. Further work is needed to understand how this risk can be diminished.
Can an electronic frailty index identify adults aged 65 and older who are at risk of CV mortality and major CV events?
Among 3 068 439 US Veterans aged 65 and older, frailty was associated with an increased risk of CV mortality at every level of frailty. Frailty was also associated with an increased risk of myocardial infarction and stroke, but not revascularization.
Both the presence and severity of frailty are associated with CV mortality and major CV events, independent of underlying CV disease.</description><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehab850</identifier><identifier>PMID: 34907422</identifier><language>eng</language><publisher>England: Oxford University Press</publisher><subject>Adult ; Aged ; Cardiovascular Diseases ; Clinical Research ; Editor's Choice ; Female ; Frailty - complications ; Frailty - epidemiology ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Male ; Myocardial Infarction - complications ; Myocardial Infarction - epidemiology ; Risk Factors ; Stroke - complications ; Stroke - epidemiology ; Veterans</subject><ispartof>European heart journal, 2022-02, Vol.43 (8), p.818-826</ispartof><rights>Published by Oxford University Press on behalf of the European Society of Cardiology 2021. This work is written by US Government employees and is in the public domain in the US.</rights><rights>Published by Oxford University Press on behalf of the European Society of Cardiology 2021. This work is written by US Government employees and is in the public domain in the US. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c399t-858c8c15c705f87af2c060ac8ae90c90dbabf18c471d2142f14cd593b96cec533</citedby><cites>FETCH-LOGICAL-c399t-858c8c15c705f87af2c060ac8ae90c90dbabf18c471d2142f14cd593b96cec533</cites><orcidid>0000-0001-7171-7437 ; 0000-0001-8431-1698 ; 0000-0003-3083-5386 ; 0000-0002-4297-6306 ; 0000-0001-6299-3763</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34907422$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shrauner, William</creatorcontrib><creatorcontrib>Lord, Emily M</creatorcontrib><creatorcontrib>Nguyen, Xuan-Mai T</creatorcontrib><creatorcontrib>Song, Rebecca J</creatorcontrib><creatorcontrib>Galloway, Ashley</creatorcontrib><creatorcontrib>Gagnon, David R</creatorcontrib><creatorcontrib>Driver, Jane A</creatorcontrib><creatorcontrib>Gaziano, J Michael</creatorcontrib><creatorcontrib>Wilson, Peter W F</creatorcontrib><creatorcontrib>Djousse, Luc</creatorcontrib><creatorcontrib>Cho, Kelly</creatorcontrib><creatorcontrib>Orkaby, Ariela R</creatorcontrib><title>Frailty and cardiovascular mortality in more than 3 million US Veterans</title><title>European heart journal</title><addtitle>Eur Heart J</addtitle><description>Frailty is associated with an increased risk of all-cause mortality and cardiovascular (CV) events. Limited data exist from the modern era of CV prevention on the relationship between frailty and CV mortality. We hypothesized that frailty is associated with an increased risk of CV mortality.
All US Veterans aged ≥65 years who were regular users of Veteran Affairs care from 2002 to 2017 were included. Frailty was defined using a 31-item previously validated frailty index, ranging from 0 to 1. The primary outcome was CV mortality with secondary analyses examining the relationship between frailty and CV events (myocardial infarction, stroke, revascularization). Survival analysis models were adjusted for age, sex, ethnicity, geographic region, smoking, hyperlipidaemia, statin use, and blood pressure medication use. There were 3 068 439 US Veterans included in the analysis. Mean age was 74.1 ± 5.8 years in 2002, 76.0 ± 8.3 years in 2014, 98% male, and 87.5% White. In 2002, the median (interquartile range) frailty score was 0.16 (0.10-0.23). This increased and stabilized to 0.19 (0.10-0.32) for 2006-14. The presence of frailty was associated with an increased risk of CV mortality at every stage of frailty. Frailty was associated with an increased risk of myocardial infarction and stroke, but not revascularization.
In this population, both the presence and severity of frailty are tightly correlated with CV death, independent of underlying CV disease. This study is the largest and most contemporary evaluation of the relationship between frailty and CV mortality to date. Further work is needed to understand how this risk can be diminished.
Can an electronic frailty index identify adults aged 65 and older who are at risk of CV mortality and major CV events?
Among 3 068 439 US Veterans aged 65 and older, frailty was associated with an increased risk of CV mortality at every level of frailty. Frailty was also associated with an increased risk of myocardial infarction and stroke, but not revascularization.
Both the presence and severity of frailty are associated with CV mortality and major CV events, independent of underlying CV disease.</description><subject>Adult</subject><subject>Aged</subject><subject>Cardiovascular Diseases</subject><subject>Clinical Research</subject><subject>Editor's Choice</subject><subject>Female</subject><subject>Frailty - complications</subject><subject>Frailty - epidemiology</subject><subject>Humans</subject><subject>Hydroxymethylglutaryl-CoA Reductase Inhibitors</subject><subject>Male</subject><subject>Myocardial Infarction - complications</subject><subject>Myocardial Infarction - epidemiology</subject><subject>Risk Factors</subject><subject>Stroke - complications</subject><subject>Stroke - epidemiology</subject><subject>Veterans</subject><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVUU1LAzEQDaJorf4AL7JHL6uTZJMmF0GKVaHgwQ-8hdls1qZkdzXZFfrvbbEWPQ3D-5jHPELOKFxS0PzKDXHhMPbLK7fAUgnYIyMqGMu1LMQ-GQHVIpdSvR2R45SWAKAklYfkiBcaJgVjI3I3i-hDv8qwrTKLsfLdFyY7BIxZ08Ueg1-Dvt0sLusX2GY8a3wIvmuzl6fs1fUuYptOyEGNIbnT7RyTl9nt8_Q-nz_ePUxv5rnlWve5EsoqS4WdgKjVBGtmQQJahU6D1VCVWNZU2WJCK0YLVtPCVkLzUkvrrOB8TK5_fD-GsnGVdW0fMZiP6BuMK9OhN_-R1i_Me_dltNIgOawNLrYGsfscXOpN45N1IWDruiEZJikUlBVSrqn0h2pjl1J09e4MBbMpwOwKMNsC1przv_l2it-P82-K1Yce</recordid><startdate>20220222</startdate><enddate>20220222</enddate><creator>Shrauner, William</creator><creator>Lord, Emily M</creator><creator>Nguyen, Xuan-Mai T</creator><creator>Song, Rebecca J</creator><creator>Galloway, Ashley</creator><creator>Gagnon, David R</creator><creator>Driver, Jane A</creator><creator>Gaziano, J Michael</creator><creator>Wilson, Peter W F</creator><creator>Djousse, Luc</creator><creator>Cho, Kelly</creator><creator>Orkaby, Ariela R</creator><general>Oxford University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-7171-7437</orcidid><orcidid>https://orcid.org/0000-0001-8431-1698</orcidid><orcidid>https://orcid.org/0000-0003-3083-5386</orcidid><orcidid>https://orcid.org/0000-0002-4297-6306</orcidid><orcidid>https://orcid.org/0000-0001-6299-3763</orcidid></search><sort><creationdate>20220222</creationdate><title>Frailty and cardiovascular mortality in more than 3 million US Veterans</title><author>Shrauner, William ; Lord, Emily M ; Nguyen, Xuan-Mai T ; Song, Rebecca J ; Galloway, Ashley ; Gagnon, David R ; Driver, Jane A ; Gaziano, J Michael ; Wilson, Peter W F ; Djousse, Luc ; Cho, Kelly ; Orkaby, Ariela R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c399t-858c8c15c705f87af2c060ac8ae90c90dbabf18c471d2142f14cd593b96cec533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Cardiovascular Diseases</topic><topic>Clinical Research</topic><topic>Editor's Choice</topic><topic>Female</topic><topic>Frailty - complications</topic><topic>Frailty - epidemiology</topic><topic>Humans</topic><topic>Hydroxymethylglutaryl-CoA Reductase Inhibitors</topic><topic>Male</topic><topic>Myocardial Infarction - complications</topic><topic>Myocardial Infarction - epidemiology</topic><topic>Risk Factors</topic><topic>Stroke - complications</topic><topic>Stroke - epidemiology</topic><topic>Veterans</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shrauner, William</creatorcontrib><creatorcontrib>Lord, Emily M</creatorcontrib><creatorcontrib>Nguyen, Xuan-Mai T</creatorcontrib><creatorcontrib>Song, Rebecca J</creatorcontrib><creatorcontrib>Galloway, Ashley</creatorcontrib><creatorcontrib>Gagnon, David R</creatorcontrib><creatorcontrib>Driver, Jane A</creatorcontrib><creatorcontrib>Gaziano, J Michael</creatorcontrib><creatorcontrib>Wilson, Peter W F</creatorcontrib><creatorcontrib>Djousse, Luc</creatorcontrib><creatorcontrib>Cho, Kelly</creatorcontrib><creatorcontrib>Orkaby, Ariela R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shrauner, William</au><au>Lord, Emily M</au><au>Nguyen, Xuan-Mai T</au><au>Song, Rebecca J</au><au>Galloway, Ashley</au><au>Gagnon, David R</au><au>Driver, Jane A</au><au>Gaziano, J Michael</au><au>Wilson, Peter W F</au><au>Djousse, Luc</au><au>Cho, Kelly</au><au>Orkaby, Ariela R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Frailty and cardiovascular mortality in more than 3 million US Veterans</atitle><jtitle>European heart journal</jtitle><addtitle>Eur Heart J</addtitle><date>2022-02-22</date><risdate>2022</risdate><volume>43</volume><issue>8</issue><spage>818</spage><epage>826</epage><pages>818-826</pages><issn>0195-668X</issn><eissn>1522-9645</eissn><abstract>Frailty is associated with an increased risk of all-cause mortality and cardiovascular (CV) events. Limited data exist from the modern era of CV prevention on the relationship between frailty and CV mortality. We hypothesized that frailty is associated with an increased risk of CV mortality.
All US Veterans aged ≥65 years who were regular users of Veteran Affairs care from 2002 to 2017 were included. Frailty was defined using a 31-item previously validated frailty index, ranging from 0 to 1. The primary outcome was CV mortality with secondary analyses examining the relationship between frailty and CV events (myocardial infarction, stroke, revascularization). Survival analysis models were adjusted for age, sex, ethnicity, geographic region, smoking, hyperlipidaemia, statin use, and blood pressure medication use. There were 3 068 439 US Veterans included in the analysis. Mean age was 74.1 ± 5.8 years in 2002, 76.0 ± 8.3 years in 2014, 98% male, and 87.5% White. In 2002, the median (interquartile range) frailty score was 0.16 (0.10-0.23). This increased and stabilized to 0.19 (0.10-0.32) for 2006-14. The presence of frailty was associated with an increased risk of CV mortality at every stage of frailty. Frailty was associated with an increased risk of myocardial infarction and stroke, but not revascularization.
In this population, both the presence and severity of frailty are tightly correlated with CV death, independent of underlying CV disease. This study is the largest and most contemporary evaluation of the relationship between frailty and CV mortality to date. Further work is needed to understand how this risk can be diminished.
Can an electronic frailty index identify adults aged 65 and older who are at risk of CV mortality and major CV events?
Among 3 068 439 US Veterans aged 65 and older, frailty was associated with an increased risk of CV mortality at every level of frailty. Frailty was also associated with an increased risk of myocardial infarction and stroke, but not revascularization.
Both the presence and severity of frailty are associated with CV mortality and major CV events, independent of underlying CV disease.</abstract><cop>England</cop><pub>Oxford University Press</pub><pmid>34907422</pmid><doi>10.1093/eurheartj/ehab850</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-7171-7437</orcidid><orcidid>https://orcid.org/0000-0001-8431-1698</orcidid><orcidid>https://orcid.org/0000-0003-3083-5386</orcidid><orcidid>https://orcid.org/0000-0002-4297-6306</orcidid><orcidid>https://orcid.org/0000-0001-6299-3763</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0195-668X |
ispartof | European heart journal, 2022-02, Vol.43 (8), p.818-826 |
issn | 0195-668X 1522-9645 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9890630 |
source | Oxford Journals Online |
subjects | Adult Aged Cardiovascular Diseases Clinical Research Editor's Choice Female Frailty - complications Frailty - epidemiology Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors Male Myocardial Infarction - complications Myocardial Infarction - epidemiology Risk Factors Stroke - complications Stroke - epidemiology Veterans |
title | Frailty and cardiovascular mortality in more than 3 million US Veterans |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T02%3A46%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Frailty%20and%20cardiovascular%20mortality%20in%20more%20than%203%20million%20US%20Veterans&rft.jtitle=European%20heart%20journal&rft.au=Shrauner,%20William&rft.date=2022-02-22&rft.volume=43&rft.issue=8&rft.spage=818&rft.epage=826&rft.pages=818-826&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehab850&rft_dat=%3Cproquest_pubme%3E2610412466%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c399t-858c8c15c705f87af2c060ac8ae90c90dbabf18c471d2142f14cd593b96cec533%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2610412466&rft_id=info:pmid/34907422&rfr_iscdi=true |